About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

RNA Nanoparticles to Overcome Treatment Resistant Breast Cancer

Font : A-A+

RNA Nanoparticles to Overcome Treatment Resistant Breast Cancer

Highlights

  • The nanodelivery system targets HER2-positive breast cancer and reduces production of protein MED1.
  • Stopping production of the protein MED1 reduces tumor growth.
  • The treatment can sensitize the cancer cells to treatment with tamoxifen, a known therapy for estrogen-driven cancer.
  • Multifunctional RNA nanoparticles that could overcome treatment resistance in breast cancer, can make existing treatments more effective in these patients.

    Researchers at the University of Cincinnati (UC) College of Medicine led by Xiaoting Zhang, PhD, associate professor in the Department of Cancer Biology at the UC College of Medicine, shows that using a nanodelivery system to target HER2-positive breast cancer and stop production of the protein MED1 could slow tumor growth, stop cancer from spreading and sensitize the cancer cells to treatment with tamoxifen.

Advertisement


MED1 is a protein often produced at abnormally high levels in breast cancer cells that when eliminated is found to stop cancer cell growth. HER2-positive breast cancer involves amplification of a gene encoding, or programming, the protein known as human epidermal growth factor receptor 2, which also promotes the growth of cancer cells.

MED1 co-produces (co-expresses) and co-amplifies with HER2 in most cases, and Zhang's previous studies have shown their interaction plays key roles in anti-estrogen treatment resistance.
Advertisement

"Most breast cancers express estrogen receptors, and the anti-estrogen drug tamoxifen has been widely used for their treatment," says Zhang, who is also a member of the Cincinnati Cancer Center and the UC Cancer Institute.

"Unfortunately, up to half of all estrogen receptor-positive tumors are either unresponsive or later develop resistance to the therapy. In this study, we have developed a highly innovative design that takes advantage of the co-overexpression of HER2 and MED1 in these tumors."

Zhang and researchers in his lab found that these RNA nanoparticles were able to selectively bind to HER2-overexpressing breast tumors, eliminating MED1 expression and significantly decreasing estrogen receptor-controlled target gene production. The RNA nanoparticles not only reduced the growth and spread of the HER2-overexpressing breast cancer tumors, but also sensitized them to tamoxifen treatment.

"These bio-safe nanoparticles efficiently targeted and penetrated into HER2-overexpressing tumors after administration in animal models," he says.

In addition, these nanoparticles also led to a dramatic reduction in the cancer stem cell content of breast tumors when combined with tamoxifen treatment. Cancer stem cells, as you know, are tumor-causing cells that are known to play essential roles in tumor spread, recurrence and therapy resistance. Eliminating these cells could represent an improved and more desirable treatment strategy for breast cancer patients.

"These findings are highly promising for potential clinical treatment of advanced metastatic and tamoxifen-resistant human breast cancer. Further studies are still needed and hopefully soon we'll be able to test our nanoparticles in clinical trials at the UC Cancer Institute's Comprehensive Breast Cancer Center."

Reference
  1. Xiaoting Zhang et al., Study shows nanoparticles could be used to overcome treatment-resistant breast cancer, ACS Nano (2016).


Source: Medindia

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Julia Samuel. (2016, December 15). RNA Nanoparticles to Overcome Treatment Resistant Breast Cancer . Medindia. Retrieved on Sep 27, 2022 from https://www.medindia.net/news/healthwatch/rna-nanoparticles-to-overcome-treatment-resistant-breast-cancer-166162-1.htm.

  • MLA

    Julia Samuel. "RNA Nanoparticles to Overcome Treatment Resistant Breast Cancer ". Medindia. Sep 27, 2022. <https://www.medindia.net/news/healthwatch/rna-nanoparticles-to-overcome-treatment-resistant-breast-cancer-166162-1.htm>.

  • Chicago

    Julia Samuel. "RNA Nanoparticles to Overcome Treatment Resistant Breast Cancer ". Medindia. https://www.medindia.net/news/healthwatch/rna-nanoparticles-to-overcome-treatment-resistant-breast-cancer-166162-1.htm. (accessed Sep 27, 2022).

  • Harvard

    Julia Samuel. 2021. RNA Nanoparticles to Overcome Treatment Resistant Breast Cancer . Medindia, viewed Sep 27, 2022, https://www.medindia.net/news/healthwatch/rna-nanoparticles-to-overcome-treatment-resistant-breast-cancer-166162-1.htm.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Breast Cancer Facts Cancer Facts Cancer Tattoos A Body Art Breasts - Structures and Types 

Most Popular on Medindia

Iron Intake Calculator Find a Doctor Post-Nasal Drip Loram (2 mg) (Lorazepam) Noscaphene (Noscapine) Drug - Food Interactions How to Reduce School Bag Weight - Simple Tips The Essence of Yoga Nutam (400mg) (Piracetam) Find a Hospital
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

RNA Nanoparticles to Overcome Treatment Resistant Breast Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests